Versant Capital Management Inc Raises Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Versant Capital Management Inc boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 4,750.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 97 shares of the biotechnology company’s stock after purchasing an additional 95 shares during the period. Versant Capital Management Inc’s holdings in Axon Enterprise were worth $58,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AXON. Larson Financial Group LLC increased its stake in shares of Axon Enterprise by 10,050.0% in the second quarter. Larson Financial Group LLC now owns 203 shares of the biotechnology company’s stock worth $60,000 after buying an additional 201 shares during the period. TD Asset Management Inc increased its position in shares of Axon Enterprise by 11.9% in the second quarter. TD Asset Management Inc now owns 28,908 shares of the biotechnology company’s stock valued at $8,506,000 after acquiring an additional 3,071 shares during the period. National Bank of Canada FI raised its stake in shares of Axon Enterprise by 19.6% during the second quarter. National Bank of Canada FI now owns 26,200 shares of the biotechnology company’s stock valued at $7,577,000 after acquiring an additional 4,286 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in shares of Axon Enterprise by 0.8% during the second quarter. Victory Capital Management Inc. now owns 42,576 shares of the biotechnology company’s stock worth $12,528,000 after purchasing an additional 326 shares during the period. Finally, Arizona State Retirement System grew its stake in shares of Axon Enterprise by 0.6% in the second quarter. Arizona State Retirement System now owns 19,693 shares of the biotechnology company’s stock worth $5,794,000 after purchasing an additional 113 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total transaction of $437,980.00. Following the completion of the transaction, the director now directly owns 26,259 shares of the company’s stock, valued at $11,500,916.82. This trade represents a 3.67 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 51,545 shares of company stock worth $31,159,317. 6.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research firms have weighed in on AXON. Northland Securities increased their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. The Goldman Sachs Group raised their price target on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Needham & Company LLC boosted their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, JMP Securities boosted their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $488.67.

Axon Enterprise Price Performance

AXON stock opened at $601.06 on Monday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a 50 day moving average price of $593.68 and a 200-day moving average price of $441.20. Axon Enterprise, Inc. has a 52-week low of $241.72 and a 52-week high of $698.67. The firm has a market capitalization of $45.83 billion, a price-to-earnings ratio of 155.31, a PEG ratio of 14.19 and a beta of 1.04.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.